Vitaly A Kushnir

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: American Infertility of New York, The Center for Human Reproduction (Chr), University of Rochester. Active years: 2018-2021.

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Location History:

Salt Lake City, UT (US) (2019)
New York, NY (US) (2018 - 2021)

Company Filing History:

3 out of 7

American Infertility of New York

patents

1 out of 1

The Center for Human Reproduction (Chr)

patent

1 out of 994

University of Rochester

patents

4. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10884003 - Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models (2021-01-05),

2. 10478473 - Compositions and methods of using anti-mullerian hormone for treatment of infertility (2019-11-19),

3. 10175252 - Diagnosis, and anti-mullerian hormone (AMH) administration for treatment, of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models (2019-01-08),

4. 9974834 - Administration to improve oocyte retrieval probabilities (2018-05-22),

Title: Vitaly A Kushnir: Innovator in Fertility Treatments

Introduction

Vitaly A Kushnir is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of fertility treatments. With a total of 4 patents, he has made strides in improving the chances of successful pregnancies for individuals facing infertility challenges.

Latest Patents

Kushnir's latest patents include innovative methods for diagnosing and administering anti-Mullerian hormone (AMH) to enhance fertility outcomes. One notable patent focuses on the diagnosis of in vitro fertilization (IVF) viability through logistic regression models. This method involves determining a subject's AMH level and categorizing their pregnancy or live birth prognosis based on established AMH ranges. The prognosis categories include good, intermediate, or poor, allowing for tailored treatment approaches. Additionally, his work on compositions and methods for using AMH aims to assist subjects with impaired fertility by increasing AMH levels or activity.

Career Highlights

Throughout his career, Kushnir has worked with reputable organizations, including American Infertility of New York. His expertise in fertility treatments has positioned him as a key figure in the field, contributing to advancements that benefit many individuals seeking to conceive.

Collaborations

Kushnir has collaborated with notable professionals in the field, including Norbert Gleicher and David H Barad. These partnerships have further enriched his research and development efforts in fertility treatments.

Conclusion

Vitaly A Kushnir's innovative work in fertility treatments showcases his dedication to improving reproductive health. His patents and collaborations reflect a commitment to advancing medical science and providing hope to those facing infertility challenges.